Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 414 GBX -2.93%
Market Cap: 438.5m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Income Statement

Earnings Waterfall
Oxford BioMedica PLC

Revenue
97.3m GBP
Cost of Revenue
-61.5m GBP
Gross Profit
35.7m GBP
Operating Expenses
-102.7m GBP
Operating Income
-67m GBP
Other Expenses
-75m GBP
Net Income
-142m GBP

Income Statement
Oxford BioMedica PLC

Rotate your device to view
Income Statement
Currency: GBP
Jun-2004 Dec-2004 Jun-2005 Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
1
N/A
1
-9%
0
-12%
1
+86%
1
-2%
1
-5%
3
+241%
7
+179%
19
+157%
18
-1%
19
+3%
19
+1%
11
-45%
11
+6%
11
-4%
8
-28%
7
-7%
8
+8%
5
-30%
5
-1%
8
+49%
14
+70%
13
-3%
16
+20%
24
+51%
28
+16%
31
+12%
38
+21%
57
+52%
67
+17%
64
-5%
64
+1%
66
+3%
88
+33%
135
+54%
143
+6%
126
-12%
140
+11%
119
-15%
90
-25%
97
+9%
Gross Profit
Cost of Revenue
0
0
0
0
0
0
(0)
(0)
(1)
(1)
(1)
(0)
1
1
(1)
(1)
(1)
(1)
(0)
(1)
(3)
(4)
(5)
(6)
(8)
(12)
(15)
(18)
(21)
(23)
(24)
(36)
(34)
(42)
(70)
(60)
(50)
(71)
(64)
(50)
(62)
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
1
+262%
2
+225%
7
+174%
17
+153%
17
0%
18
+4%
19
+5%
12
-36%
12
-2%
10
-13%
7
-30%
6
-10%
7
+10%
5
-27%
4
-18%
5
+20%
9
+80%
8
-9%
10
+21%
16
+56%
16
+2%
16
+0%
19
+20%
37
+91%
44
+20%
39
-11%
28
-28%
32
+12%
46
+46%
65
+42%
83
+27%
76
-8%
69
-9%
55
-21%
40
-28%
36
-10%
Operating Income
Operating Expenses
(13)
(11)
(11)
(12)
(16)
(22)
(24)
(26)
(29)
(26)
(22)
(21)
(20)
(20)
(21)
(18)
(18)
(18)
(17)
(17)
(17)
(20)
(22)
(24)
(28)
(27)
(25)
(27)
(31)
(36)
(46)
(41)
(44)
(51)
(45)
(62)
(94)
(121)
(139)
(126)
(103)
Selling, General & Administrative
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(4)
(5)
(4)
(4)
(6)
(5)
(4)
(4)
(4)
(5)
(4)
(3)
(3)
(3)
(4)
(5)
(7)
(8)
(6)
(5)
(7)
(7)
(7)
(9)
(12)
(13)
(11)
(13)
(15)
(26)
(28)
(25)
(25)
(27)
Research & Development
(11)
(9)
(9)
(9)
(14)
(20)
(21)
(22)
(24)
(22)
(17)
(15)
(15)
(16)
(17)
(15)
(13)
(14)
(14)
(14)
(14)
(17)
(19)
(20)
(24)
(24)
(22)
(21)
(25)
(30)
(33)
(23)
(20)
(30)
(29)
(40)
(53)
(61)
(65)
(59)
(44)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
(0)
0
(0)
0
(0)
0
0
0
0
0
0
0
0
0
0
0
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
3
3
3
2
2
2
1
(3)
(6)
(12)
(10)
(4)
(6)
(15)
(32)
(49)
(41)
(32)
Operating Income
(12)
N/A
(11)
+12%
(11)
+1%
(11)
-3%
(15)
-38%
(21)
-36%
(22)
-3%
(19)
+10%
(12)
+41%
(9)
+21%
(4)
+58%
(2)
+43%
(8)
-276%
(8)
+1%
(10)
-28%
(11)
-10%
(11)
+1%
(10)
+6%
(11)
-9%
(13)
-12%
(12)
+10%
(11)
+8%
(13)
-27%
(14)
-5%
(13)
+9%
(11)
+11%
(9)
+21%
(8)
+10%
6
N/A
8
+34%
(6)
N/A
(13)
-98%
(13)
-1%
(5)
+62%
20
N/A
21
+5%
(18)
N/A
(52)
-189%
(84)
-62%
(86)
-3%
(67)
+22%
Pre-Tax Income
Interest Income Expense
1
1
1
1
1
2
2
2
2
2
1
1
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(3)
(8)
(9)
(5)
(4)
(7)
(3)
(6)
(8)
(2)
(2)
(1)
(1)
(9)
(16)
(9)
(4)
(5)
Non-Reccuring Items
(2)
(2)
0
0
0
0
(0)
(0)
(0)
(5)
(9)
(4)
0
(4)
(7)
(3)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
22
(98)
(99)
Total Other Income
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
(0)
(1)
(0)
0
(0)
(0)
(0)
0
(0)
(0)
(0)
0
(0)
(0)
(1)
(1)
Pre-Tax Income
(13)
N/A
(11)
+13%
(10)
+13%
(10)
-5%
(14)
-37%
(19)
-38%
(20)
-5%
(18)
+13%
(9)
+47%
(12)
-28%
(11)
+6%
(5)
+55%
(7)
-45%
(12)
-60%
(17)
-46%
(14)
+17%
(11)
+23%
(10)
+6%
(11)
-10%
(13)
-13%
(12)
+8%
(11)
+8%
(14)
-28%
(17)
-23%
(20)
-20%
(20)
+0%
(14)
+30%
(12)
+17%
(1)
+94%
5
N/A
(12)
N/A
(21)
-70%
(15)
+29%
(7)
+56%
19
N/A
20
+6%
(27)
N/A
(46)
-72%
(71)
-54%
(189)
-166%
(172)
+9%
Net Income
Tax Provision
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
4
4
4
4
4
3
0
3
4
5
2
0
(0)
(1)
0
1
1
4
4
Income from Continuing Operations
(12)
(10)
(9)
(9)
(13)
(18)
(18)
(15)
(7)
(10)
(9)
(4)
(6)
(10)
(16)
(13)
(9)
(9)
(10)
(11)
(10)
(9)
(10)
(13)
(16)
(17)
(11)
(9)
(0)
8
(8)
(16)
(13)
(6)
19
19
(27)
(45)
(70)
(184)
(168)
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
6
9
27
26
Net Income (Common)
(12)
N/A
(10)
+11%
(9)
+16%
(9)
-3%
(13)
-41%
(18)
-38%
(18)
-3%
(15)
+16%
(7)
+53%
(10)
-40%
(9)
+6%
(4)
+63%
(6)
-66%
(10)
-76%
(16)
-51%
(13)
+19%
(9)
+25%
(9)
+8%
(10)
-10%
(11)
-15%
(10)
+10%
(9)
+14%
(10)
-15%
(13)
-30%
(16)
-25%
(17)
-2%
(11)
+36%
(9)
+15%
(0)
+95%
8
N/A
(8)
N/A
(16)
-106%
(13)
+22%
(6)
+50%
19
N/A
19
+3%
(25)
N/A
(39)
-60%
(62)
-57%
(157)
-156%
(142)
+10%
EPS (Diluted)
-1.49
N/A
-1.32
+11%
-1.11
+16%
-1.13
-2%
-1.21
-7%
-1.67
-38%
-1.65
+1%
-1.35
+18%
-0.64
+53%
-0.89
-39%
-0.84
+6%
-0.31
+63%
-0.51
-65%
-0.9
-76%
-0.84
+7%
-0.68
+19%
-0.5
+26%
-0.32
+36%
-0.35
-9%
-0.39
-11%
-0.34
+13%
-0.21
+38%
-0.2
+5%
-0.25
-25%
-0.31
-24%
-0.3
+3%
-0.18
+40%
-0.15
+17%
-0.02
+87%
0.11
N/A
-0.11
N/A
-0.22
-100%
-0.16
+27%
-0.08
+50%
0.22
N/A
0.22
N/A
-0.26
N/A
-0.41
-58%
-0.64
-56%
-1.63
-155%
-1.35
+17%

See Also

Discover More